Aisling Capital Management LP Biomea Fusion, Inc. Transaction History
Aisling Capital Management LP
- $286 Million
- Q1 2025
A detailed history of Aisling Capital Management LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 798,757 shares of BMEA stock, worth $1.33 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
798,757
Previous 798,757
-0.0%
Holding current value
$1.33 Million
Previous $3.1 Million
45.11%
% of portfolio
0.59%
Previous 1.14%
Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
109Shares Held
16.1MCall Options Held
229KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.93 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.29 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA626KShares$1.04 Million0.0% of portfolio
-
State Street Corp Boston, MA597KShares$991,6400.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $48.6M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...